Andreas P. Wagner Sells 14,878 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHCGet Free Report) insider Andreas P. Wagner sold 14,878 shares of the stock in a transaction dated Wednesday, February 12th. The shares were sold at an average price of $14.38, for a total transaction of $213,945.64. Following the completion of the transaction, the insider now directly owns 200,885 shares in the company, valued at $2,888,726.30. The trade was a 6.90 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Alignment Healthcare Trading Down 1.4 %

ALHC stock opened at $13.68 on Friday. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. The company’s 50-day simple moving average is $12.95 and its 200 day simple moving average is $11.59. Alignment Healthcare, Inc. has a 52 week low of $4.46 and a 52 week high of $15.82. The company has a market capitalization of $2.62 billion, a PE ratio of -17.77 and a beta of 1.50.

Analysts Set New Price Targets

ALHC has been the topic of several research analyst reports. Stephens reissued an “overweight” rating and issued a $17.00 price objective on shares of Alignment Healthcare in a research report on Thursday, January 2nd. UBS Group increased their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a research report on Wednesday, October 30th. Stifel Nicolaus increased their price objective on shares of Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a research report on Tuesday, January 14th. Finally, Barclays upped their price target on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 30th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Alignment Healthcare currently has an average rating of “Moderate Buy” and an average price target of $11.88.

Check Out Our Latest Report on ALHC

Institutional Investors Weigh In On Alignment Healthcare

A number of large investors have recently bought and sold shares of the company. Creative Planning grew its stake in Alignment Healthcare by 20.0% during the third quarter. Creative Planning now owns 12,442 shares of the company’s stock worth $147,000 after buying an additional 2,072 shares in the last quarter. Rhumbline Advisers grew its stake in Alignment Healthcare by 2.2% during the fourth quarter. Rhumbline Advisers now owns 135,704 shares of the company’s stock worth $1,527,000 after buying an additional 2,937 shares in the last quarter. MetLife Investment Management LLC grew its stake in Alignment Healthcare by 5.6% during the fourth quarter. MetLife Investment Management LLC now owns 61,344 shares of the company’s stock worth $690,000 after buying an additional 3,256 shares in the last quarter. Alliancebernstein L.P. grew its stake in Alignment Healthcare by 2.8% during the fourth quarter. Alliancebernstein L.P. now owns 119,440 shares of the company’s stock worth $1,344,000 after buying an additional 3,300 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. grew its stake in Alignment Healthcare by 15.0% during the fourth quarter. Adage Capital Partners GP L.L.C. now owns 34,497 shares of the company’s stock worth $388,000 after buying an additional 4,497 shares in the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Alignment Healthcare Company Profile

(Get Free Report)

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Further Reading

Insider Buying and Selling by Quarter for Alignment Healthcare (NASDAQ:ALHC)

Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.